Full name
SYNAPSA MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIA
uses securityreCAPTCHA
32.50.Z - Manufacture of medical and dental instruments and supplies
01.16.Z - Growing of fibre crops
10.41.Z - Manufacture of oils and other fluid fats
13.92 - Manufacture of made-up textile articles
59.11.Z - Motion picture, video and television programme production activities
63.12.Z - Web portals
69.20.Z - Accounting, bookkeeping and auditing activities; tax consultancy
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.90.A - Physiotherapeutical activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 3,3 | -0,7 | -1,5 | -105,5 |
Gross profit (loss) | 3,7 | 0,5 | 3,5 | 639,6 |
EBITDA | 4,3 | 1,1 | 4 | 249,8 |
Short time liabilities | 9 | 8 | 5,9 | -26,5 |
Other operating costs | 0,3 | 0,6 | 0,2 | -60,1 |
Equity capital | 4,2 | 4,1 | 7,5 | 84,7 |
Operating profit (EBIT) | 3,7 | 0,5 | 3,4 | 562,3 |
Assets | 13,2 | 12,8 | 14,1 | 10,1 |
Net profit (loss) | 3,2 | 0,4 | 3,5 | 791,4 |
Cash | 0,5 | 0,4 | 0,2 | -59,6 |
Net income from sale | 39,7 | 26,4 | 21,3 | -19,4 |
Liabilities and provisions for liabilities | 9 | 8,7 | 6,5 | -24,8 |
Working assets | 7,5 | 6,8 | 8,3 | 20,7 |
Other income costs | 0,7 | 1,8 | 5,1 | 181,3 |
Depreciation | 0,6 | 0,6 | 0,6 | -1,3 |
% | % | % | p.p. | |
Profitability of capital | 75,4 | 9,5 | 45,9 | 36,4 |
Equity capital to total assets | 31,9 | 31,9 | 53,5 | 21,6 |
Gross profit margin | 9,2 | 1,8 | 16,2 | 14,4 |
EBITDA Margin | 10,9 | 4,3 | 18,8 | 14,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 83 | 111 | 101 | -10 |
Current financial liquidity indicator | 0.8263119459152222 | 0.8557290434837341 | 1.4042994976043701 | 0,5 |
Net dept to EBITDA | 0.029228724539279938 | -0.028689472004771233 | 0.03881852328777313 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane